News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Respirics, Inc. Announces Launch Of MD Turbo(TM)



6/14/2006 11:19:43 AM

RALEIGH, N.C.--(BUSINESS WIRE)--June 14, 2006--Respirics Inc. announces the commercial launch of MD Turbo, a companion product designed to solve two of the biggest problems patients with Asthma & COPD have with their pressurized metered dose inhalers (pMDI). MD Turbo will be marketed in the United States by TEAMM Pharmaceuticals, Inc., a subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI - News).

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES